1404048-75-4Relevant academic research and scientific papers
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmor
Johnson, Christopher N.,Ahn, Jong Sook,Buck, Ildiko M.,Chiarparin, Elisabetta,Day, James E. H.,Hopkins, Anna,Howard, Steven,Lewis, Edward J.,Martins, Vanessa,Millemaggi, Alessia,Munck, Joanne M.,Page, Lee W.,Peakman, Torren,Reader, Michael,Rich, Sharna J.,Saxty, Gordon,Smyth, Tomoko,Thompson, Neil T.,Ward, George A.,Williams, Pamela A.,Wilsher, Nicola E.,Chessari, Gianni
, p. 7314 - 7329 (2018/09/06)
Inhibitor of apoptosis proteins (IAPs) are promising anticancer targets, given their roles in the evasion of apoptosis. Several peptidomimetic IAP antagonists, with inherent selectivity for cellular IAP (cIAP) over X-linked IAP (XIAP), have been tested in
